Sign up to save your podcasts
Or
Share Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates
Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as emerging evidence on the role of antibody-drug conjugates for patients with select actionable genomic alterations.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
3030 ratings
Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as emerging evidence on the role of antibody-drug conjugates for patients with select actionable genomic alterations.
CME information and select publications here.
More shows like Lung Cancer Update
View all
NEJM This Week
319 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Breast Cancer Update
69 Listeners
Hematologic Oncology Update
76 Listeners
Prostate Cancer Update
13 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
13 Listeners
Dermatologic Oncology Update
0 Listeners
Lung Cancer CancerCare Connect Education Workshops
6 Listeners
Research To Practice | Oncology Videos
116 Listeners
ASCO Daily News
57 Listeners
The Long Run with Luke Timmerman
124 Listeners
ASCO Guidelines
44 Listeners
Lung Cancer Considered
29 Listeners
Oncology Today with Dr Neil Love
56 Listeners
Business Of Biotech
86 Listeners
Two Onc Docs
185 Listeners